Incidence of "Muscle Pain" After Short-acting Relaxants

The use of short-acting relaxants in E.C.T.

SINCE the introduction of curare to modify the contractions in E.C.T. , the use of relaxants has become standard psychiatric practice. These substances reduce the risk of fractures and enable treatment to be given to patients who would other wise be denied it owing to risks arising from concomitant physical disease. During recent years great efforts have been made to simplify the technique of m...

The incidence of postoperative residual curarization following the use of intermediate-acting muscle relaxants and related factors.

PURPOSE To evaluate the incidence of residual curarization (RC) and related risk factors in the early and late postoperative periods in patients receiving general anesthesia with intermediate-acting muscle relaxants. METHODS Two-hundred and eight American Society of Anesthesiologists class I and II patients, aged 18-70 years, who underwent general anesthesia with intermediate-acting muscle re...

Use of muscle relaxants.

Muscle relaxants for pain management in rheumatoid arthritis.

BACKGROUND Pain management is a high priority for patients with rheumatoid arthritis (RA). Muscle relaxants include drugs that reduce muscle spasm (for example benzodiazepines such as diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan) and non-benzodiazepines such as metaxalone (Skelaxin) or a combination of paracetamol and orphenadrine (Muscol)) and drugs that prevent increased muscle to...

Cardiovascular effects of muscle relaxants.